George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArrow Explor. Regulatory News (AXL)

Share Price Information for Arrow Explor. (AXL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.50
Bid: 20.00
Ask: 21.00
Change: -2.75 (-11.83%)
Spread: 1.00 (5.00%)
Open: 22.50
High: 20.50
Low: 20.30
Prev. Close: 23.25
AXL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operations Update, PDMR Exercise of Options & TVR

23 Dec 2022 07:00

RNS Number : 6941K
Arrow Exploration Corp.
23 December 2022
 

 

 

NOT FOR RELEASE, DISTRIBUTION, PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

 

OPERATIONS UPDATE, PDMR EXERCISE OF OPTIONS AND TVR

 

CALGARY, December 23, 2022 - Arrow Exploration Corp. (AIM: AXL; TSXV: AXL), the high-growth operator with a portfolio of assets across key Colombian hydrocarbon basins, is pleased to provide an operations update and report on the granting and exercise of options by certain Directors and PDMRs. 

 

Operations Update

Drilling Rig Mobilized to Rio Cravo Este Multiwell Pad

Arrow has initiated the drilling rig move to Rio Cravo Este (RCE) to further exploit the Carbonera Sandstone reservoir. Three additional infill wells will be drilled in Q1 2023 with RCE-3 expected to spud in January 2023. RCE-4 and RCE-5 will be drilled in sequence. The drilling rig was initially delayed due to a different operator experiencing operational issues. The infill wells have similar productivity potential to RCE-2 and RCS-1 which are currently producing 850 BOPD net, well above forecasted rates. RCE-2 was paid out in 37 days with an onstream net cost of $4.2MM.

Upon completion of the RCE-3, RCE-4 and RCE-5 wells, the Company is contemplating drilling two to three additional wells into the Gacheta Sandstone reservoir in the fault bounded RCE structure. RCE-2 tested rates exceeding 700 BOPD gross from the Gacheta Sandstone. Dedicated Gacheta wells would likely spud in Q3 2023.

Arrow has also completed preparation of an additional field to be used for production water dispersion. In combination, the two fields are expected to meet the Company's water disposal requirements until a water disposal well is drilled which is expected mid-2023.

 

Carrizales Norte Operations

Earlier this month Arrow began construction of the road, pad and cellars for the three planned Carrizales Norte (CN) wells which are expected to be drilled sometime between March and June 2023. The road and pad being constructed are being built to meet all weather conditions. This will allow the Company to continue capital activities as well as move production in the summer and winter seasons. 

The Company is in discussions with a separate drilling company to bring in a second drilling rig to drill CN-1, CN-2 and CN-3. This would advance the drilling of Carrizales Norte by approximately six weeks.

 

3D Seismic Project, Tapir Block

Arrow has commenced the 134 square kilometer 3D seismic project on the Tapir block. Hiring in the local communities and the required surface land work began on schedule. The 3D seismic project is scheduled to be completed in Q1 2023. This 3D survey will define multiple fault-bounded structures which are the prevailing trapping mechanisms in the Llanos Basin. Existing 2D seismic data has indicated multiple leads on the Tapir Block and the 3D will resolve existing and additional leads and prospects. Initial drilling on defined low risk prospects could occur as early as Q4 2023.

 

Workover Program

Arrow is continuing to recomplete existing wells that display additional production upside in unperforated zones. This program has been successful in both the RCE field and the Oso Pardo Field. The Company is also considering additional perforations on RCS-1 once RCE-3 RCE-4 and RCE-5 are completed.

 

Balance Sheet

Arrow has a healthy balance sheet with all operations being supported by cash on hand and operational cash flow. Cash balance as of 1 December 2022 was $14MM.

 

Options Exercised

Arrow announces that certain Directors and Management exercised 2,983,332 options at GBP 0.07625 per common share of no par value ("Common Share"). A summary of the options exercised is as follows:

 

 

Options Exercised

 

Strike Price

Market Price at Exercise

Marshall Abbott

816,666

GBP 0.07625

GBP 0.1620

Gage Jull

750,000

GBP 0.07625

GBP 0.1620

Ravi Sharma

333,333

GBP 0.07625

GBP 0.1620

Anthony Zaidi

333,333

GBP 0.07625

GBP 0.1620

Joe McFarlane

750,000

GBP 0.07625

GBP 0.1620

Total

2,983,332

 

 

The option exercise was accepted by the Company on December 21, 2022 once legal advice was received. The options, which were set to expire mid-2023, have been exercised at this time since the Company is expected to be continually operationally active over the next six months with limited periods when Directors would be able to exercise options. The option holders elected to use a "cashless" exercise of options. Using this method, which is permissible under the terms of the Company's share option plan, the Company pays the option holder the value of the option (market price less strike price) from cash reserves. Accordingly, no new shares were issued for the option exercise.

Following the exercise of the options referred to above, there has accordingly been no change in the holding of PDMR's and Directors. Mr. Abbott holds 3,579,802 Common Shares (representing 1.6% of the issued Common Shares), Mr. Jull holds 3,995,672 Common Shares (1.8 %), Mr. McFarlane holds 3,865,629 Common Shares (1.8 %), Mr. Sharma holds 13,370 Common Shares (0.0 %) and Mr. Zaidi holds 0 Common Shares (0.0 %). 

 

Options Granted

The Board of Directors granted 5,478,332 options on 21 December 2022, pursuant to the Company's Stock Option Plan to certain Directors and senior management as detailed below:

Name

Role

Options Granted

Vesting

Expiry

Marshall Abbott

Director

527,222

December 21, 2023

June 21, 2023

527,222

December 21, 2024

June 21, 2024

527,222

December 21, 2025

June 21, 2025

Gage Jull

Director

505,000

December 21, 2023

June 21, 2023

505,000

December 21, 2024

June 21, 2024

505,000

December 21, 2025

June 21, 2025

Ravi Sharma

Director

144,444

December 21, 2023

June 21, 2023

144,444

December 21, 2024

June 21, 2024

144,445

December 21, 2025

June 21, 2025

Anthony Zaidi

Director

144,444

December 21, 2023

June 21, 2023

144,444

December 21, 2024

June 21, 2024

144,445

December 21, 2025

June 21, 2025

Joe McFarlane

Director

505,000

December 21, 2023

June 21, 2023

505,000

December 21, 2024

June 21, 2024

505,000

December 21, 2025

June 21, 2025

 

All options granted have an exercise price equal to the market closing price on 21 December 2022, GPB 0.1675. The options will vest one third each year for the next three years. The options will expire six months after they vest. 

 

Total Voting Rights

 

The Company also announces that it has issued 500,000 Common Shares (the "New Common Shares") pursuant to the exercise of warrants issued at the Company's IPO in October 2021. All of the New Common Shares issued during the month were issued under the Company's existing block listing entitlement. The Company does not anticipate any further shares being issued under the block listing throughout the remainder of December.

Following the issue of the New Common Shares the issued share capital of the Company comprises 218,401,931 common shares with one vote per share. Therefore, this figure can be used by shareholders as the denominator for the calculations by which to determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

For further Information, contact:

Arrow Exploration

 

Marshall Abbott, CEO

+1 403 651 5995

Joe McFarlane, CFO

+1 403 818 1033

 

 

Brookline Public Relations, Inc.

Shauna MacDonald

 

+1 403 538 5645

 

 

Canaccord Genuity (Nominated Advisor and Joint Broker)

 

Henry Fitzgerald-O'Connor

James Asensio

Gordon Hamilton

+44 (0)20 7523 8000

 

Auctus Advisors (Joint Broker)

 

Jonathan Wright (Corporate)

+44 (0)7711 627449

Rupert Holdsworth Hunt (Broking)

 

 

Camarco (Financial PR)

 

Georgia Edmonds

+44 (0)20 3781 8331

Rebecca Waterworth

 

Billy Clegg

 

About Arrow Exploration Corp.

Arrow Exploration Corp. (operating in Colombia via a branch of its 100% owned subsidiary Carrao Energy S.A.) is a publicly traded company with a portfolio of premier Colombian oil assets that are underexploited, under-explored and offer high potential growth. The Company's business plan is to expand oil production from some of Colombia's most active basins, including the Llanos, Middle Magdalena Valley (MMV) and Putumayo Basin. The asset base is predominantly operated with high working interests, and the Brent-linked light oil pricing exposure combines with low royalties to yield attractive potential operating margins. Arrow's 50% interest in the Tapir Block is contingent on the assignment by Ecopetrol SA of such interest to Arrow. Arrow's seasoned team is led by a hands-on executive team supported by an experienced board. Arrow is listed on the AIM market of the London Stock Exchange and on TSX Venture Exchange under the symbol "AXL".

Forward-looking Statements

This news release contains certain statements or disclosures relating to Arrow that are based on the expectations of its management as well as assumptions made by and information currently available to Arrow which may constitute forward-looking statements or information ("forward-looking statements") under applicable securities laws. All such statements and disclosures, other than those of historical fact, which address activities, events, outcomes, results or developments that Arrow anticipates or expects may, could or will occur in the future (in whole or in part) should be considered forward-looking statements. In some cases, forward-looking statements can be identified by the use of the words "continue", "expect", "opportunity", "plan", "potential" and "will" and similar expressions. The forward-looking statements contained in this news release reflect several material factors and expectations and assumptions of Arrow, including without limitation, Arrow's evaluation of the impacts of COVID-19, the potential of Arrow's Colombian and/or Canadian assets (or any of them individually), the prices of oil and/or natural gas, and Arrow's business plan to expand oil and gas production and achieve attractive potential operating margins. Arrow believes the expectations and assumptions reflected in the forward-looking statements are reasonable at this time, but no assurance can be given that these factors, expectations, and assumptions will prove to be correct.

The forward-looking statements included in this news release are not guarantees of future performance and should not be unduly relied upon. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company undertakes no obligations to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

 

Details of the person discharging managerial responsibilities / person closely associated

Name

1. Marshall Abbott

2. Gage Jull

3. Joe McFarlane

4. Ravi Sharma

5. Anthony Zaidi

Reason for the notification

Position/status

1. Director

2. Director

3. PDMR (non-director)

4. Director

5. Director

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer

or auction monitor

Name

Arrow Exploration Corp.

LEI

9845000FDF0856QD9031

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Identification code

Common Shares of nil par value

 

ISIN: CA04274P1053

 

Nature of the transaction

1. Exercise of options for cash

2. Exercise of options for cash

3. Exercise of options for cash

4. Exercise of options for cash

5. Exercise of options for cash

Price(s) and volume(s)

 

Exercise

 

 

 

 

Name

Exercise price

Options

 

 

 

1. Marshall Abbott

GBP 0.07625

816,666

 

 

 

2. Gage Jull

GBP 0.07625

750,000

 

 

 

3. Joe McFarlane

GBP 0.07625

750,000

 

 

 

4. Ravi Sharma

GBP 0.07625

333,333

 

 

 

5. Anthony Zaidi

GBP 0.07625

333,333

 

 

 

 

 

 

 

 

 

 

 

 

 

Aggregated information

N/A

Date of the transaction

1. 21 December 2022

2. 21 December 2022

3. 21 December 2022

4. 21 December 2022

5. 21 December 2022

Place of the transaction

Outside a trading venue

 

Details of the person discharging managerial responsibilities / person closely associated

Name

6. Marshall Abbott

7. Gage Jull

8. Joe McFarlane

9. Ravi Sharma

10. Anthony Zaidi

Reason for the notification

Position/status

6. Director

7. Director

8. PDMR (non-director)

9. Director

10. Director

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer

or auction monitor

Name

Arrow Exploration Corp.

LEI

9845000FDF0856QD9031

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Identification code

Common Shares of nil par value

 

ISIN: CA04274P1053

 

Nature of the transaction

6. Grant of stock options

7. Grant of stock options

8. Grant of stock options

9. Grant of stock options

10.  Grant of stock options

Price(s) and volume(s)

 

 

 

 

 

 

Name

Exercise price

Options

 

 

 

6. Marshall Abbott

GBP 0.1675

1,581,666

 

 

 

7. Gage Jull

GBP 0.1675

1,515,000

 

 

 

8. Joe McFarlane

GBP 0.1675

1,515,000

 

 

 

9. Ravi Sharma

GBP 0.1675

433,333

 

 

 

10. Anthony Zaidi

GBP 0.1675

433,333

 

 

 

 

 

 

 

 

 

 

 

 

 

Aggregated information

N/A

Date of the transaction

6. 21 December 2022

7. 21 December 2022

8. 21 December 2022

9. 21 December 2022

10.  21 December 2022

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDBBDDUDDDGDD
Date   Source Headline
29th Apr 20247:00 amRNS2023 Annual Results, MD&A and Reserves Report
2nd Apr 20245:10 pmRNSTR-1: Notification of major holdings
2nd Apr 20247:00 amRNSPDMR Exercise of Options
28th Mar 20247:00 amRNS2023 Year-End Reserves and Operations Update
20th Feb 20247:00 amRNSCN-4 and CN-5 Results
17th Jan 20247:00 amRNSOperations Update and PDMR Exercise of Options
4th Jan 20247:00 amRNSOperations Update and 2024 Guidance
29th Nov 20237:00 amRNSQ3 2023 Interim Results
16th Nov 20237:00 amRNSRCE-6 Update and Operations Update
7th Nov 20237:00 amRNSTR-1: Notification of major holdings
2nd Nov 20237:00 amRNSBlock Listing Update
26th Oct 20233:42 pmRNSTR-1: Notification of major holdings
25th Oct 20237:00 amRNSExercise of Warrants and TVR
20th Oct 202312:11 pmRNSTR-1: Notification of major holdings
19th Oct 20237:29 amRNSTR-1: Notification of major holdings
18th Oct 20233:21 pmRNSExercise of Warrants and Operations Update
18th Oct 20237:00 amRNSExercise of Warrants and Operations Update
29th Sep 20237:00 amRNSGrant Of Stock Options And TVR Update
21st Sep 20237:00 amRNSResult of AGM
18th Sep 20237:00 amRNSCN-3 Production and Production Update
11th Sep 20237:00 amRNSArrow Announces Maiden Carrizales Norte Reserves
7th Sep 20237:00 amRNSArrow Announces CN-3 Well Update
1st Sep 20237:00 amRNSTotal Voting Rights
29th Aug 20237:00 amRNSArrow Announces Q2 2023 Interim Results
21st Aug 20237:00 amRNSFiling of AGM Materials
1st Aug 20237:00 amRNSTotal Voting Rights
27th Jul 20237:05 amRNSIan Langley Appointed to Board of Directors
27th Jul 20237:00 amRNSCN-2 Well Results
25th Jul 20237:00 amRNSTR-1: Notification of major holdings
3rd Jul 20237:00 amRNSTotal Voting Rights Update
19th Jun 20237:00 amRNSCN-1 RESULTS AND OPERATIONS UPDATE
8th Jun 20237:00 amRNSCN-1 WELL UPDATE
1st Jun 20237:00 amRNSTotal Voting Rights
30th May 20237:00 amRNSCN-1 WELL UPDATE
30th May 20237:00 amRNSQ1 2023 INTERIM RESULTS
15th May 20237:00 amRNSREACHING TARGET DEPTH ON THE CN-1 WELL
9th May 20237:00 amRNSARROW ANNOUNCES BLOCKLISTING UPDATE
4th May 20237:00 amRNSSPUDDING OF CARRIZALES NORTE-1 WELL
2nd May 20237:00 amRNS2022 ANNUAL RESULTS, MD&A AND RESERVES REPORT
14th Apr 20237:00 amRNSARROW ANNOUNCES RCE-5 RESULTS & OPERATIONS UPDATE
3rd Apr 20237:00 amRNSRCE-5 Well Update
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 20237:00 amRNS2022 Year-End Reserves
24th Mar 20237:00 amRNSStandard form for notification of major holdings
22nd Mar 20237:00 amRNSRCE-4 Results and Operations Update
13th Mar 20237:00 amRNSRCE-4 Well Update
10th Mar 20237:00 amRNSARROW ANNOUNCES RESIGNATION OF DIRECTOR
3rd Mar 20237:00 amRNSRCE-3 Well Update
28th Feb 20237:00 amRNSTotal Voting Rights
21st Feb 20237:00 amRNSUpdate on RCE-3 Well and Operations Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.